Implication of xanthine oxidase in muscle oxidative stress in COPD patients

References

• Couillard A, Maltais F, Saey D, Debigare R, Michaud A, Koechlin C, LeBlanc P, Prefaut C. Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167: 1664–1669
   PubMed Web of Science ®Google Scholar
• van Helvoort HA, Heijdra YF, de Boer RC, Swinkels A, Thijs HM, Dekhuijzen PN. Six-minute walking-induced systemic inflammation and oxidative stress in muscle-wasted COPD patients. Chest 2007; 131: 439–445
   PubMed Web of Science ®Google Scholar
• Mador MJ, Deniz O, Aggarwal A, Kufel TJ. Quadriceps fatigability after single muscle exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 168: 102–108
   PubMed Web of Science ®Google Scholar
• Saey D, Debigare R, LeBlanc P, Mador MJ, Cote CH, Jobin J, Maltais F. Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 168: 425–430
   PubMed Web of Science ®Google Scholar
• Koechlin C, Couillard A, Simar D, Cristol JP, Bellet H, Hayot M, Prefaut C. Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease?. Am J Respir Crit Care Med 2004; 169: 1022–1027
   PubMed Web of Science ®Google Scholar
• McCord JM, Roy RS, Schaffer SW. Free radicals and myocardial ischemia. The role of xanthine oxidase. Adv Myocardiol 1985; 5: 183–189
   PubMedGoogle Scholar
• Li H, Samouilov A, Liu X, Zweier JL. Characterization of the magnitude and kinetics of xanthine oxidase-catalyzed nitrate reduction: evaluation of its role in nitrite and nitric oxide generation in anoxic tissues. Biochemistry 2003; 42: 1150–1159
   PubMed Web of Science ®Google Scholar
• Hellsten Y, Frandsen U, Orthenblad N, Sjodin B, Richter EA. Xanthine oxidase in human skeletal muscle following eccentric exercise: a role in inflammation. J Physiol 1997; 498: 239–248
   PubMed Web of Science ®Google Scholar
• Devrim E, Avci A, Erguder IB, Karagenc N, Kulah B, Durak I. Activities of xanthine oxidase and superoxide dismutase enzymes in rat intestinal tissues in sepsis. J Trauma 2008; 64: 733–735
   PubMedGoogle Scholar
• O'Brien JD, Ferguson JH, Howlett SE. Effects of ischemia and reperfusion on isolated ventricular myocytes from young adult and aged Fischer 344 rat hearts. Am J Physiol Heart Circ Physiol 2008; 294: H2174–H2183
   Web of Science ®Google Scholar
• Van Wylen DG. Effect of ischemic preconditioning on interstitial purine metabolite and lactate accumulation during myocardial ischemia. Circulation 1994; 89: 2283–2289
   PubMed Web of Science ®Google Scholar
• Pouw EM, Schols AM, van der Vusse GJ, Wouters EF. Elevated inosine monophosphate levels in resting muscle of patients with stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 453–457
   PubMed Web of Science ®Google Scholar
• Hellsten Y, Sjodin B, Richter EA, Bangsbo J. Urate uptake and lowered ATP levels in human muscle after high-intensity intermittent exercise. Am J Physiol 1998; 274: E600–E606
   PubMed Web of Science ®Google Scholar
• Heunks LM, Vina J, van Herwaarden CL, Folgering HT, Gimeno A, Dekhuijzen PN. Xanthine oxidase is involved in exercise-induced oxidative stress in chronic obstructive pulmonary disease. Am J Physiol 1999; 277: R1697–R1704
   PubMedGoogle Scholar
• Coronell C, Orozco-Levi M, Mendez R, Ramirez-Sarmiento A, Galdiz JB, Gea J. Relevance of assessing quadriceps endurance in patients with COPD. Eur Respir J 2004; 24: 129–136
   PubMed Web of Science ®Google Scholar
• Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532–555
   PubMed Web of Science ®Google Scholar
• Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault J. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16: 5–40
   PubMedGoogle Scholar
• Andersen P, Adams RP, Sjogaard G, Thorboe A, Saltin B. Dynamic knee extension as model for study of isolated exercising muscle in humans. J Appl Physiol 1985; 59: 1647–1653
   PubMed Web of Science ®Google Scholar
• Serres I, Gautier V, Varray A, Prefaut C. Impaired skeletal muscle endurance related to physical inactivity and altered lung function in COPD patients. Chest 1998; 113: 900–905
   PubMed Web of Science ®Google Scholar
• Couillard A, Koechlin C, Cristol JP, Varray A, Prefaut C. Evidence of local exercise-induced systemic oxidative stress in chronic obstructive pulmonary disease patients. Eur Respir J 2002; 20: 1123–1129
   PubMed Web of Science ®Google Scholar
• Milne GL, Morrow JD. Isoprostanes and related compounds: update 2006. Antioxid Redox Signal 2006; 8: 1379–1384
   PubMed Web of Science ®Google Scholar
• Nourooz-Zadeh J, Gopaul NK, Barrow S, Mallet AI, Anggard EE. Analysis of F2-isoprostanes as indicators of non-enzymatic lipid peroxidation in vivo by gas chromatography-mass spectrometry: development of a solid-phase extraction procedure. J Chromatogr B Biomed Appl 1995; 667: 199–208
   PubMed Web of Science ®Google Scholar
• Witko-Sarsat V, Nguyen Khoa T, Jungers P, Drueke T, Descamps-Latscha B. Advanced oxidation protein products: oxidative stress markers and mediators of inflammation in uremia. Adv Nephrol Necker Hosp 1998; 28: 321–341
   PubMedGoogle Scholar
• Cachia O, Leger CL, Boulot P, Vernet MH, Michel F, Crastes de Paulet A, Descomps B. Red blood cell vitamin E concentrations in fetuses are related to but lower than those in mothers during gestation. A possible association with maternal lipoprotein (a) plasma levels. Am J Obstet Gynecol 1995; 173: 42–51
   PubMed Web of Science ®Google Scholar
• Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158–169
   PubMed Web of Science ®Google Scholar
• Morrow JD, Awad JA, Wu A, Zackert WE, Daniel VC, Roberts LJ, 2nd. Nonenzymatic free radical-catalyzed generation of thromboxane-like compounds (isothromboxanes) in vivo. J Biol Chem 1996; 271: 23185–23190
   PubMed Web of Science ®Google Scholar
• Morrow JD, Roberts LJ, 2nd. Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress. Methods Enzymol 1999; 300: 3–12
   PubMed Web of Science ®Google Scholar
• Awad JA, Morrow JD, Takahashi K, Roberts LJ, 2nd. Identification of non-cyclooxygenase-derived prostanoid (F2-isoprostane) metabolites in human urine and plasma. J Biol Chem 1993; 268: 4161–4169
   PubMed Web of Science ®Google Scholar
• Lee CY, Jenner AM, Halliwell B. Rapid preparation of human urine and plasma samples for analysis of F2-isoprostanes by gas chromatography-mass spectrometry. Biochem Biophys Res Commun 2004; 320: 696–702
   PubMed Web of Science ®Google Scholar
• Mori TA, Croft KD, Puddey IB, Beilin LJ. An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry. Anal Biochem 1999; 268: 117–125
   PubMed Web of Science ®Google Scholar
• Walter MF, Blumberg JB, Dolnikowski GG, Handelman GJ. Streamlined F2-isoprostane analysis in plasma and urine with high-performance liquid chromatography and gas chromatography/mass spectroscopy. Anal Biochem 2000; 280: 73–79
   PubMed Web of Science ®Google Scholar
• Kaneda H, Taguchi J, Ogasawara K, Aizawa T, Ohno M. Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis 2002; 162: 221–225
   PubMed Web of Science ®Google Scholar
• Morena M, Martin-Mateo M, Cristol JP, Canaud B. [Oxidative stress, hemo-incompatibility and complications of long-term dialysis]. Nephrologie 2002; 23: 201–208
   PubMedGoogle Scholar
• Van Helvoort HA, Heijdra YF, Thijs HM, Vina J, Wanten GJ, Dekhuijzen PN. Exercise-induced systemic effects in muscle-wasted patients with COPD. Med Sci Sports Exerc 2006; 38: 1543–1552
   PubMed Web of Science ®Google Scholar
• Koechlin C, Maltais F, Saey D, Michaud A, LeBlanc P, Hayot M, Prefaut C. Hypoxaemia enhances peripheral muscle oxidative stress in chronic obstructive pulmonary disease. Thorax 2005; 60: 834–841
   PubMed Web of Science ®Google Scholar
• Okamoto T, Kanazawa H, Hirata K, Yoshikawa J. Evaluation of oxygen uptake kinetics and oxygen kinetics of peripheral skeletal muscle during recovery from exercise in patients with chronic obstructive pulmonary disease. Clin Physiol Funct Imaging 2003; 23: 257–262
   PubMed Web of Science ®Google Scholar
• Granger DN, Rutili G, McCord JM. Superoxide radicals in feline intestinal ischemia. Gastroenterology 1981; 81: 22–29
   PubMed Web of Science ®Google Scholar
• Vina J, Servera E, Asensi M, Sastre J, Pallardo FV, Ferrero JA, Garcia-De-La-Asuncion J, Anton V, Marin J. Exercise causes blood glutathione oxidation in chronic obstructive pulmonary disease: prevention by O2 therapy. J Appl Physiol 1996; 81: 2198–2202
   PubMed Web of Science ®Google Scholar
• Murrell GA, Rapeport WG. Clinical pharmacokinetics of allopurinol. Clin Pharmacokinet 1986; 11: 343–353
   PubMed Web of Science ®Google Scholar
• Moorhouse PC, Grootveld M, Halliwell B, Quinlan JG, Gutteridge JM. Allopurinol and oxypurinol are hydroxyl radical scavengers. FEBS Lett 1987; 213: 23–28
   PubMed Web of Science ®Google Scholar
• Griffiths HR, Moller L, Bartosz G, Bast A, Bertoni-Freddari C, Collins A, Cooke M, Coolen S, Haenen G, Hoberg AM, Loft S, Lunec J, Olinski R, Parry J, Pompella A, Poulsen H, Verhagen H, Astley SB. Biomarkers. Mol Aspects Med 2002; 23: 101–208
   PubMed Web of Science ®Google Scholar
• Ziment I. Acetylcysteine: a drug that is much more than a mucokinetic. Biomed Pharmacother 1988; 42: 513–519
   PubMed Web of Science ®Google Scholar
• Bachur JA, Garcia SB, Vannucchi H, Jordao AA, Chiarello PG, Zucoloto S. Anti-oxidative systems in rat skeletal muscle after acute physical exercise. Appl Physiol Nutr Metab 2007; 32: 190–196
   PubMed Web of Science ®Google Scholar
• Cappola TP, Kass DA, Nelson GS, Berger RD, Rosas GO, Kobeissi ZA, Marban E, Hare JM. Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation 2001; 104: 2407–2411
   PubMed Web of Science ®Google Scholar
• Duncan JG, Ravi R, Stull LB, Murphy AM. Chronic xanthine oxidase inhibition prevents myofibrillar protein oxidation and preserves cardiac function in a transgenic mouse model of cardiomyopathy. Am J Physiol Heart Circ Physiol 2005; 289: H1512–H1518
   Web of Science ®Google Scholar
• Engberding N, Spiekermann S, Schaefer A, Heineke A, Wiencke A, Muller M, Fuchs M, Hilfiker-Kleiner D, Hornig B, Drexler H, Landmesser U. Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug?. Circulation 2004; 110: 2175–2179
   PubMed Web of Science ®Google Scholar
• Minhas KM, Saraiva RM, Schuleri KH, Lehrke S, Zheng M, Saliaris AP, Berry CE, Barouch LA, Vandegaer KM, Li D, Hare JM. Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy. Circ Res 2006; 98: 271–279
   PubMed Web of Science ®Google Scholar
• Stull LB, Leppo MK, Szweda L, Gao WD, Marban E. Chronic treatment with allopurinol boosts survival and cardiac contractility in murine postischemic cardiomyopathy. Circ Res 2004; 95: 1005–1011
   PubMed Web of Science ®Google Scholar